Provided by Tiger Trade Technology Pte. Ltd.

Theravance Biopharma

17.03
+0.02000.12%
Post-market: 17.030.00000.00%16:10 EDT
Volume:332.38K
Turnover:5.66M
Market Cap:882.64M
PE:16.30
High:17.07
Open:17.02
Low:17.00
Close:17.01
52wk High:21.03
52wk Low:13.08
Shares:51.83M
Float Shares:25.78M
Volume Ratio:0.89
T/O Rate:1.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.05
EPS(LYR):2.06
ROE:20.91%
ROA:1.33%
PB:3.05
PE(LYR):8.27

Loading ...

Major Insider Move Rocks Theravance Biopharma Shares

TIPRANKS
·
Jul 02

Theravance Biopharma 10% Owner Eli Samaha Sells 336,697 Common Shares Worth $5.78 Million

Reuters
·
Jul 02

PRESS Digest-canada - June 30

Reuters
·
Jun 30

Theravance Biopharma Cut to Neutral from Buy by BTIG

Dow Jones
·
Jun 29

Zymeworks’ TBPH Acquisition Seen as Cash-Flow Accretive, Supports Buy Rating and Unchanged $34 Price Target

TIPRANKS
·
Jun 29

BTIG Downgrades Theravance Biopharma to Neutral From Buy

MT Newswires Live
·
Jun 29

Analysts Offer Insights on Healthcare Companies: Evommune, Inc. (EVMN) and Theravance Biopharma (TBPH)

TIPRANKS
·
Jun 29

Theravance Biopharma downgraded to Neutral from Buy at BTIG

TIPRANKS
·
Jun 29

Theravance Biopharma Inc : Btig Cuts to Neutral from Buy

THOMSON REUTERS
·
Jun 29

Zymeworks Down 6.1%

THOMSON REUTERS
·
Jun 29

Theravance Biopharma Inc : Jonestrading Cuts to Hold Rating

THOMSON REUTERS
·
Jun 29

Zymeworks Posts Investor Presentation on Planned Theravance Biopharma Acquisition for Yupelri Cash Flows

Reuters
·
Jun 29

Deals of the Day-mergers and Acquisitions

Reuters
·
Jun 29

Why This Biotech Stock is Falling After a $929 Million Buyout Lifeline

Dow Jones
·
Jun 29

Theravance Biopharma: Co to Pay $32.5 Mln Termination Fee to Zymeworks, if Deal Terminated Under Certain Circumstances

THOMSON REUTERS
·
Jun 29

Theravance Biopharma to be acquired by Zymeworks for $17.00 per share in cash

TIPRANKS
·
Jun 29

Theravance Biopharma Shares Fall 3.3% Premarket; Co to be Acquired by Zymeworks for $17 Per Share in Cash Plus a Contingent Value Right

THOMSON REUTERS
·
Jun 29

Zymeworks to Acquire Theravance Biopharma for USD 17 Per Share in USD 929 Million Deal

Reuters
·
Jun 29

Theravance Biopharma - Strategic Review Committee and Board Unanimously Approve and Recommend Deal

THOMSON REUTERS
·
Jun 29

Theravance Biopharma - Deal Represents Equity Value of About $929 Mln

THOMSON REUTERS
·
Jun 29